Multiple Sclerosis (MS) is an incurable disease that affects the brain and central nervous system, disrupting the flow of information inside the brain and from the brain to other parts of the body. MS is an autoimmune disorder in which the immune system attacks its own body, resulting in the deterioration of fatty myelin sheath. This demyelination creates scars in the central nervous system that interfere with the transmission of electric impulses and therefore disrupts communication throughout the body. The condition can cause patients to lose vision, muscle control, balance, motor control, strength, and other normal bodily functions. Most of these symptoms are severe and painful, and MS patients commonly describe feeling a "pins and needles" sensation.
Cannabis acts as an analgesic and an anti-inflammatory, making it an ideal candidate in targeting the two principle symptoms of MS. Because MS frequently interferes with ones motor skills, patients who choose to medicate with cannabis report inhalation or ingestion as their most viable method of intake. There are various clinical studies to support the success stories of many MS patients. One report on animal models found the use of synthetic cannabinoids resulted in significant neuroprotection. The researchers concluded cannabis and its cannabinoid components could not only target the debilitating symptoms of MS, but also combat the core disease itself by slowing neurodegenerative processes. Other studies have found inhaled cannabis to be superior to placebo and conventional pharmaceutical treatments and therapies when it comes to reducing pain intensity and spasticity in patients with MS.
This information has been approved by our Chief Medical Officer. Read more about MS and cannabis on Whaxy.